Johan Tijhuis

Oncodrone BV develops novel therapeutics for epithelial derived malignancies including prostate, breast, lung, pancreas and bladder cancer. It focuses on developing novel therapeutics for advanced cancer by targeting: Epithelial-to-Mesenchymal Transition (EMT) and Androgen Receptor (AR) Signaling. The company was founded in 2013 and is headquartered in Nijmegen, the Netherlands.

Specs Compound Handling BV provides compound management services. It supplies research compounds to the life science industry. The firm offers services from its two main logistic centers in The Netherlands and Maryland, USA. The company was founded in 1987 and is headquartered in Zoetermeer, the Netherlands.